{"id":96556,"date":"2010-03-04T14:27:56","date_gmt":"2010-03-04T13:27:56","guid":{"rendered":"https:\/\/clinical.r-biopharm.com\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/"},"modified":"2010-03-04T14:27:56","modified_gmt":"2010-03-04T13:27:56","slug":"ridascreen-norovirus-3rd-generation-antigen-eia-en","status":"publish","type":"post","link":"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/","title":{"rendered":"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA (en)"},"content":{"rendered":"

Your first step in the diagnosis of noroviral
\ngastroenteritis outbreaks, powered by R-Biopharm<\/strong><\/p>\n

Noroviruses, the most common cause of acute gastroenteritis are estimated
\nto cause 21 million people illnesses among people of all ages in the US each
\nyear. Noroviruses are responsible for around 50% of all foodborne outbreaks in the United States.<\/p>\n

<\/p>\n

    \n
  1. 1in 14 Americans becomes ill every year. In 2006 a total of 1316 acute gastroenteritis outbreaks were reported to the Centers for Disease Control and Prevention.<\/li>\n
  2. Outbreaks occur in a wide range of settings, including schools, hospitals, long-term care facilities, restaurants and cruise ships. More than 90% of the non-bacterial and approximately 50% of all-cause epidemic gastroenteritis worldwide can be attributed to Norovirus.<\/li>\n
  3. According to the Maryland Department of Health and Mental Hygiene norovirus was the laboratory confirmed etiology in 89% of the gastroenteritis outbreaks from 2005 to 2009. In the U.S norovirus accounts for more than 235,000 clinical visits, 91,000 emergency room visits and 23,000 hospitalizations among children younger than 5 years of age.<\/li>\n<\/ol>\n

    The RIDASCREEN\u00ae Norovirus 3rd Generation EIA provides fast and reliable results for the diagnosis of noroviral gastroenteritis.<\/p>\n

    \"Graphik<\/a><\/p>\n

    For further information about the RIDASCREEN\u00ae Norovirus 3rd Generation
    \nplease contact our local R-Biopharm Inc. representative<\/p>\n

    R-Biopharm Inc.
    \n870 Vossbrink Dr., Washington, MO 63090, USA
    \nPhone: (877) 789 3033 Fax: (866) 922 5856
    \nmail for ordering:     sales@r-biopharm.com<\/a>
    \nmail for information:     info@r-biopharm.com<\/a><\/p>\n

    1. Centers for Disease Control and Prevention, CDC Technical Fact Sheet about Norovirus 2010
    \n2. Centers for Disease Control and Prevention, MMWR 2007, 56(33):842-846
    \n3. Patel MM et al., EID 2008, 14(8), 1224-31
    \n4. Maryland Department of Health and Mental Hygiene. Available at:
    \nhttp:\/\/www.edcp.org\/html\/norovirus.cfm. \u00a0\u00a0\u00a0Accessed 23 February 2010<\/p>\n","protected":false},"excerpt":{"rendered":"

    Your first step in the diagnosis of noroviral gastroenteritis outbreaks, powered by R-Biopharm Noroviruses, the most common cause of acute gastroenteritis are estimated to cause 21 million people illnesses among people of all ages in the US each year. Noroviruses are responsible for around 50% of all foodborne outbreaks in the United States.<\/p>\n","protected":false},"author":27,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[476,470],"tags":[],"acf":[],"yoast_head":"\nRIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA (en) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA (en) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\" \/>\n<meta property=\"og:description\" content=\"Your first step in the diagnosis of noroviral gastroenteritis outbreaks, powered by R-Biopharm Noroviruses, the most common cause of acute gastroenteritis are estimated to cause 21 million people illnesses among people of all ages in the US each year. Noroviruses are responsible for around 50% of all foodborne outbreaks in the United States.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/\" \/>\n<meta property=\"og:site_name\" content=\"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\" \/>\n<meta property=\"article:published_time\" content=\"2010-03-04T13:27:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/devclinical.r-biopharm.com\/wp-content\/uploads\/2012\/08\/graphik_laboratories-3.jpg\" \/>\n<meta name=\"author\" content=\"Janine Dege\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Janine Dege\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/\",\"url\":\"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/\",\"name\":\"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA (en) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\",\"isPartOf\":{\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#website\"},\"datePublished\":\"2010-03-04T13:27:56+00:00\",\"dateModified\":\"2010-03-04T13:27:56+00:00\",\"author\":{\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\"},\"breadcrumb\":{\"@id\":\"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/devclinical.r-biopharm.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#website\",\"url\":\"https:\/\/devdevclinical.r-biopharm.com\/\",\"name\":\"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8\",\"description\":\"A Division of the R-Biopharm Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/devdevclinical.r-biopharm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\",\"name\":\"Janine Dege\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g\",\"caption\":\"Janine Dege\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA (en) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"it_IT","og_type":"article","og_title":"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA (en) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","og_description":"Your first step in the diagnosis of noroviral gastroenteritis outbreaks, powered by R-Biopharm Noroviruses, the most common cause of acute gastroenteritis are estimated to cause 21 million people illnesses among people of all ages in the US each year. Noroviruses are responsible for around 50% of all foodborne outbreaks in the United States.","og_url":"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/","og_site_name":"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","article_published_time":"2010-03-04T13:27:56+00:00","og_image":[{"url":"https:\/\/devclinical.r-biopharm.com\/wp-content\/uploads\/2012\/08\/graphik_laboratories-3.jpg"}],"author":"Janine Dege","twitter_misc":{"Written by":"Janine Dege","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/","url":"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/","name":"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA (en) - \ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","isPartOf":{"@id":"https:\/\/devdevclinical.r-biopharm.com\/#website"},"datePublished":"2010-03-04T13:27:56+00:00","dateModified":"2010-03-04T13:27:56+00:00","author":{"@id":"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f"},"breadcrumb":{"@id":"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/devclinical.r-biopharm.com\/it\/news\/ridascreen-norovirus-3rd-generation-antigen-eia-en\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/devclinical.r-biopharm.com\/it\/"},{"@type":"ListItem","position":2,"name":"RIDASCREEN\u00ae Norovirus 3rd Generation antigen EIA"}]},{"@type":"WebSite","@id":"https:\/\/devdevclinical.r-biopharm.com\/#website","url":"https:\/\/devdevclinical.r-biopharm.com\/","name":"\ud83d\udea8\ud83d\udea8\ud83d\udea8 Staging!!! Clinical Diagnostics \ud83d\udea8\ud83d\udea8\ud83d\udea8","description":"A Division of the R-Biopharm Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/devdevclinical.r-biopharm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f","name":"Janine Dege","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/devdevclinical.r-biopharm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bb89e83feb98f248810cb1fb31dc223f?s=96&d=mm&r=g","caption":"Janine Dege"}}]}},"_links":{"self":[{"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/96556"}],"collection":[{"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/comments?post=96556"}],"version-history":[{"count":0,"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/96556\/revisions"}],"wp:attachment":[{"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/media?parent=96556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/categories?post=96556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/devclinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/tags?post=96556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}